NASRIN JALILIAN, FIROOZEH VEISI, NEGIN REZAVAND*
Maternity Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
Background: Global estimates indicate that cervical cancer is the second most common cancer among women following breast
cancer. Therefore, screening for cervical cancer is considered an effective method in early diagnosis and treatment of this condition.
Here, we studied screening tests results to determine the frequency of abnormal cervical cytologic findings.
Methods: This study had two phases. The first phase was conducted from March 2007 to March 2008 (400 subjects). The
second phase lasted from March 2011 to March 2012 (208 subjects). All infertile women (either primary causes or secondary ones)
who presented to our university infertility clinic to receive treatments were included.
Results: Cervical cytology reports were unsatisfactory in 10 subjects (1.7%) and abnormal in three patients (0.5%). Most
cases whose reports were unsatisfactory were documented in the first phase of the study (i.e., 9 patients, 90%).
Conclusion: Cervical screening with Pap smear enables early diagnosis and management of cervical abnormalities and consequently
a decrease in the rate of invasive cervical cancers. It is suggested to conduct studies with larger sample sizes to ensure the
beneficial effects of cervical screening.
Screening, cervical cancer, infertility.